Cerebrospinal Fluid in PASC: A Window into the COVID Mind

PASC 中的脑脊液:了解新冠病毒思维的窗口

基本信息

  • 批准号:
    10554972
  • 负责人:
  • 金额:
    $ 97.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-04 至 2024-02-28
  • 项目状态:
    已结题

项目摘要

Abstract Although severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is considered a respiratory pathogen, myriad neurologic complications including confusion, stroke, and neuromuscular disorders manifest during acute COVID-19. Furthermore, maladies such as impaired concentration, headache, sensory disturbances, depression, and even psychosis may persist for months following infection, as part of a constellation of symptoms now called Post Acute Sequelae of COVID-19 (PASC). The pathophysiological mechanisms of nervous system PASC (NS-PASC) are not well understood, although evidence to date implicates immune dysfunction, including non-specific neuroinflammation and anti-neural autoimmune dysregulation1. With millions of individuals affected, nervous system complications pose public health challenges for rehabilitation and recovery and major disruptions in the workforce. There is an urgent need to understand the pathophysiology of these disorders and develop disease modifying therapies. Through the COVID Mind Study at Yale, we have initiated a longitudinal study to investigate the pathogenic mechanisms of NS-PASC through examination of cerebrospinal fluid (CSF), blood, and magnetic resonance imaging (MRI), alongside detailed clinical data in individuals with NS-PASC. In Aim 1, we will define the clinical and immunological features through deep immunophenotyping of the CSF and blood, including assessment of brain autoimmunity and altered T cell function. In Aim 2, we will assess for SARS-CoV-2 persistence in the CSF and blood through single copy PCR and highly sensitive viral antigen detection assays. In Aim 3, we will measure objective markers of nervous system dysfunction through brain MRI, neurocognitive testing, and CSF and blood markers of neuronal injury, and will perform multivariate analysis to assess for the relationship between immune perturbations, viral persistence, and objective measures of neurologic injury.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joshua Charles Cyktor其他文献

Joshua Charles Cyktor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joshua Charles Cyktor', 18)}}的其他基金

CNS Viral Persistence and Neuropsychiatric Perturbations in HIV: Single cell and Molecular Interrogation
HIV 中的中枢神经系统病毒持久性和神经精神扰动:单细胞和分子审讯
  • 批准号:
    10563136
  • 财政年份:
    2021
  • 资助金额:
    $ 97.07万
  • 项目类别:
CNS Viral Persistence and Neuropsychiatric Perturbations in HIV: Single cell and Molecular Interrogation
HIV 中的中枢神经系统病毒持久性和神经精神扰动:单细胞和分子审讯
  • 批准号:
    10258495
  • 财政年份:
    2021
  • 资助金额:
    $ 97.07万
  • 项目类别:
CNS Viral Persistence and Neuropsychiatric Perturbations in HIV: Single cell and Molecular Interrogation
HIV 中的中枢神经系统病毒持久性和神经精神扰动:单细胞和分子审讯
  • 批准号:
    10395614
  • 财政年份:
    2021
  • 资助金额:
    $ 97.07万
  • 项目类别:
Cerebrospinal Fluid in PASC: A Window into the COVID Mind
PASC 中的脑脊液:了解新冠病毒思维的窗口
  • 批准号:
    10788666
  • 财政年份:
    2021
  • 资助金额:
    $ 97.07万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 97.07万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了